Advanced Insights into the Etiology of Lymphoma

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Causes, Screening and Diagnosis".

Deadline for manuscript submissions: 15 April 2026 | Viewed by 108

Special Issue Editors


E-Mail Website
Guest Editor
1. Division of Computational Biology, Department of Quantitative Health Science, Mayo Clinic, Rochester, MN 55905, USA
2. Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA
Interests: identifying inherited and acquired genetic susceptibility to lymphoma; chronic lymphocytic leukemia (CLL) and precursor condition; monoclonal B-cell lymphocytosis (MBLs)

E-Mail Website
Guest Editor
Division of Epidemiology, Department of Quantitative Health Science, Mayo Clinic, Rochester, MN 55905, USA
Interests: identifying the causes of lymphoma, including environmental, lifestyle, genetic and biological factors that are responsible for causing lymphoma, a cancer of the immune system that increased dramatically during the second half of the 20th century

Special Issue Information

Dear Colleagues,

Lymphoma arises from a complex interplay of genetic, viral, immune, and environmental factors.   While certain etiological contributors—such as inherited genetic predispositions, viral infections, and immunodeficiency—are well established, new research is continuing to reveal additional drivers of lymphomagenesis.   This Special Issue will highlight both known and emerging factors in lymphoma etiology, providing a comprehensive view of the mechanisms underlying disease initiation and progression across different lymphoma subtypes.

We invite submissions investigating the etiological factors contributing to the risk of lymphoma overall or lymphoma subtypes.   Studies must focus on human populations and be research articles, not review papers.   Topics of interest include research on genetic predisposition, clonal hematopoiesis, clonal evolution, viral and microbial influences, immune dysregulation, environmental exposures, and novel biomarkers.   Epidemiological studies, biomarker-based risk assessment, and multi-omics analyses are particularly encouraged.   Submissions based on animal models or cell line studies will not be considered.

By compiling cutting-edge research on lymphoma etiology, this Special Issue will enhance our understanding of disease mechanisms, refine risk prediction models, and inform strategies for early detection and prevention.

Prof. Dr. Susan L. Slager
Prof. Dr. James R. Cerhan
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • lymphoma etiology
  • genetic predisposition
  • clonal hematopoiesis
  • precursor conditions
  • risk stratification
  • viral oncogenesis
  • non-Hodgkin lymphoma
  • Hodgkin lymphoma

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop